Equity Profile

DGX

Quest Diagnostics Incorporated

Health CareHealth Care Services$22.2B

Jul21Tue

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Quest Diagnostics Incorporated (DGX) is a leading provider of diagnostic testing services, crucial for healthcare providers in diagnosing and monitoring diseases. As part of the Health Care sector, Quest plays a vital role in patient care, especially as demand for lab services continues to grow amid ongoing health challenges.

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its services and capture market share, which is essential for long-term success.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

DGX Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+2.79%

Avg Stock Reaction

+3.85%

Last Quarter Recap

In Q1-2026, Quest Diagnostics reported an EPS of $2.50, beating expectations by 5.44%. The stock reacted positively, gaining 4.45% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are generally optimistic about Quest Diagnostics' upcoming earnings, given its consistent track record of beating EPS estimates.

Bull Case

If Quest continues its trend of strong earnings surprises, it could signal robust demand for its services and further stock appreciation.

Bear Case

Conversely, any signs of slowing revenue growth or increased competition could raise concerns about the company's future performance.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2-2026?

Given Quest's history of beating EPS estimates, this figure will be critical in determining market sentiment.

How is revenue growth trending compared to previous quarters?

Investors will be keen to understand if the company can maintain its growth trajectory amid potential market challenges.

Edge

What the Street Is Missing

Why consensus could be wrong

The market may underestimate Quest's ability to maintain its growth trajectory, especially if it can capitalize on emerging health trends.

Supporting Evidence

Quest has consistently beaten EPS estimates, indicating strong operational execution.

Options pricing suggests a lower expected move compared to historical averages, which may not reflect the company's potential.

The lack of recent peer reports may lead to a misjudgment of Quest's competitive position.

Key Risk

If revenue growth comes in below expectations, it could undermine confidence in Quest's market position.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is crucial as it will indicate whether Quest can sustain its growth momentum in a competitive landscape.

Bull Confirmed If

An EPS of $2.60 or higher would confirm the bull case, indicating strong operational performance.

Bear Confirmed If

An EPS below $2.40 could signal trouble, confirming the bear case and raising concerns about future growth.

Pre-Earnings Positioning

Options Market

Implied Move

±2.31%

Historical Avg

±5.7%

Pricing cheap

The options market is pricing a modest move of about 2.31%, suggesting that investors expect limited volatility around the earnings announcement.

Options are pricing ±2.3% while DGX has averaged ±5.7% over the last 8 prints — setup is pricing cheap.

Detail

ATM IV

0.3%

30d HV

24.2%

Calls (31K)P/C Ratio: 0.25Puts (1K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.5%, with a raw directional average of +2.9% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Quest beats expectations, history suggests a potential stock increase of around 3.85%, confirming strong demand for its services.

In-Line / Cautious

If results are in line but management expresses caution, the stock may see a muted reaction as investors reassess growth prospects.

Miss

A miss could lead to a decline, with historical patterns suggesting an average drop of around 3.85%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new service offerings or partnerships that could drive growth.
2Insights into cost management strategies and their impact on margins.
3Comments on competitive pressures and how Quest plans to address them.
4Updates on patient volume trends and their implications for future revenue.
5Management's outlook on the healthcare landscape and potential challenges.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

ICICI Bank Limited

Company Snapshot

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its services and capture market share, which is essential for long-term success.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

DGX Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+2.79%

Avg Stock Reaction

+3.85%

Last Quarter Recap

In Q1-2026, Quest Diagnostics reported an EPS of $2.50, beating expectations by 5.44%. The stock reacted positively, gaining 4.45% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are generally optimistic about Quest Diagnostics' upcoming earnings, given its consistent track record of beating EPS estimates.

Bull Case

If Quest continues its trend of strong earnings surprises, it could signal robust demand for its services and further stock appreciation.

Bear Case

Conversely, any signs of slowing revenue growth or increased competition could raise concerns about the company's future performance.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2-2026?

Given Quest's history of beating EPS estimates, this figure will be critical in determining market sentiment.

How is revenue growth trending compared to previous quarters?

Investors will be keen to understand if the company can maintain its growth trajectory amid potential market challenges.

Edge

What the Street Is Missing

Why consensus could be wrong

The market may underestimate Quest's ability to maintain its growth trajectory, especially if it can capitalize on emerging health trends.

Supporting Evidence

Quest has consistently beaten EPS estimates, indicating strong operational execution.

Options pricing suggests a lower expected move compared to historical averages, which may not reflect the company's potential.

The lack of recent peer reports may lead to a misjudgment of Quest's competitive position.

Key Risk

If revenue growth comes in below expectations, it could undermine confidence in Quest's market position.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is crucial as it will indicate whether Quest can sustain its growth momentum in a competitive landscape.

Bull Confirmed If

An EPS of $2.60 or higher would confirm the bull case, indicating strong operational performance.

Bear Confirmed If

An EPS below $2.40 could signal trouble, confirming the bear case and raising concerns about future growth.

Pre-Earnings Positioning

Options Market

Implied Move

±2.31%

Historical Avg

±5.7%

Pricing cheap

The options market is pricing a modest move of about 2.31%, suggesting that investors expect limited volatility around the earnings announcement.

Options are pricing ±2.3% while DGX has averaged ±5.7% over the last 8 prints — setup is pricing cheap.

Detail

ATM IV

0.3%

30d HV

24.2%

Calls (31K)P/C Ratio: 0.25Puts (1K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Quest beats expectations, history suggests a potential stock increase of around 3.85%, confirming strong demand for its services.

In-Line / Cautious

If results are in line but management expresses caution, the stock may see a muted reaction as investors reassess growth prospects.

Miss

A miss could lead to a decline, with historical patterns suggesting an average drop of around 3.85%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new service offerings or partnerships that could drive growth.
2Insights into cost management strategies and their impact on margins.
3Comments on competitive pressures and how Quest plans to address them.
4Updates on patient volume trends and their implications for future revenue.
5Management's outlook on the healthcare landscape and potential challenges.